|Bid||0.1450 x 0|
|Ask||0.1700 x 0|
|Day's Range||0.1600 - 0.1650|
|52 Week Range||0.0600 - 0.2800|
|Beta (5Y Monthly)||2.14|
|PE Ratio (TTM)||0.26|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jul. 21, 2005|
|1y Target Est||N/A|
EDMONTON, AB , June 4, 2020 /CNW/ - Quest PharmaTech Inc. (QPT.V) ("Quest" or the "Company") wishes to provide a corporate update following the entering into of the asset transfer transaction between 40% owned OncoQuest Inc. ("OncoQuest") and Korean publicly traded Dual Industrial Co., Ltd.(078590.KQ) ('Dual") and the first closing under that transaction. A second closing of the transaction will occur upon completion of all transfers of legal title and registrations for OncoQuest's immunotherapy assets to Dual, which is expected to occur no later than December 31, 2020 . A minimum of US$62.5 million of these bonds may be redeemed for cash not later than December 31, 2020 and would be used by OncoQuest, in part, to pay for the costs of the transaction, including income taxes.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
VANCOUVER, BC , June 2, 2020 /CNW/ - Trading resumes in: Company: Quest PharmaTech Inc. TSX-Venture Symbol: QPT Resumption (ET): 9:30 6/3/2020 IIROC can make a decision to impose a temporary suspension ...